- Home
- MRK
as 01-21-2025 4:00pm EST
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | KENILWORTH |
| Market Cap: | 260.8B | IPO Year: | N/A |
| Target Price: | $124.64 | AVG Volume (30 days): | 9.7M |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.78 | EPS Growth: | 165.47 |
| 52 Week Low/High: | $94.48 - $134.63 | Next Earning Date: | 02-04-2025 |
| Revenue: | $63,174,000,000 | Revenue Growth: | 6.51% |
| Revenue Growth (this year): | 7.5% | Revenue Growth (next year): | 5.14% |
Latest Merck & Company Inc. (new) News
MRK Breaking Stock News: Dive into MRK Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others
Benzinga
a day ago
Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income
Insider Monkey
2 days ago
Merck & Co., Inc. (MRK): A Bull Case Theory
Insider Monkey
2 days ago
Jim Cramer on Merck & Co., Inc. (MRK): ‘Right Now, The Stock’s Well-ensconced A Few Points Around 52-week Low’
Insider Monkey
3 days ago
Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025?
Yahoo Finance
3 days ago
Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
TipRanks
4 days ago
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
Yahoo Finance Video
4 days ago
Medicare to negotiate prices on 15 drugs, including Ozempic
Compare MRK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRK Merck & Company Inc. (new) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.